Keyphrases
Hypoxic-ischemic Encephalopathy
100%
Untargeted Metabolomics Analysis
100%
Perinatal Asphyxia
100%
Pathway Discovery
100%
Metabolomic Pathways
100%
At Birth
27%
Path Analysis
18%
Metabolic Features
18%
Cord Blood
9%
Acetone
9%
Phosphate
9%
New Drug Targets
9%
Healthy Controls
9%
Metabolic Effects
9%
Metabolic Pathway
9%
Genome Analysis
9%
Potential Biomarkers
9%
Direct Infusion
9%
Group Control
9%
Metabolic Potential
9%
Melatonin
9%
Leucine
9%
FT-ICR Mass Spectrometry
9%
Metabolic Alterations
9%
Early Biomarker
9%
Kynurenine
9%
Untargeted Metabolomics
9%
Direct Treatment
9%
Tryptophan Metabolism
9%
Pyrimidine Biosynthesis
9%
Metabolite Annotation
9%
D-erythrose
9%
Severity Grading
9%
False Discovery
9%
Medicine and Dentistry
Hypoxic-Ischemic Encephalopathy
100%
Metabolomics
100%
Perinatal Asphyxia
100%
Biological Marker
18%
Metabolite
18%
Infusion
9%
Cord Blood
9%
Metabolism
9%
Leucine
9%
Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
9%
Tryptophan Metabolism
9%
Melatonin
9%
Kynurenine
9%
Pyrimidine Metabolism
9%
Biochemistry, Genetics and Molecular Biology
Metabolomics
100%
Metabolite
66%
Metabolic Pathway
33%
Fourier Transform Ion Cyclotron Resonance Mass Spectrometry
33%
Melatonin
33%
Leucine
33%
Tryptophan Metabolism
33%
Kynurenine
33%
Pyrimidine Metabolism
33%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxic Ischemic Encephalopathy
100%
Perinatal Asphyxia
100%
Biological Marker
18%
Tryptophan
9%
Leucine
9%
Melatonin
9%
Kynurenine
9%
Pyrimidine
9%
Neuroscience
Brain Ischemia
100%
Metabolic Pathway
18%
Mass Spectrometry
9%
Melatonin
9%
Leucine
9%
Tryptophan
9%
Kynurenine
9%
Pyrimidine
9%